# RAG Benchmark — 2026-09-06

## Sonar Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=20 → 20 in context · 8192 ctx · emb 2.82s · gen 231.42s · total 236.5s_

**Retrieved** (ranked by store ranker):
1. **From Mindless to Mindful Practice — Cognitive Bias and Clinical Decision Making.pdf** — 0.0323 (rrf) — _#### june 27, 2013 the resident and the attending physician regarding the management of posterio_
2. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0240 (rrf) — _# support Student 52 female (69.3 %) 75 (72.8 %) 25.53 (SD = 5.02) 25 (range = 19–52) 4.57 (SD =_
3. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0213 (rrf) — _# decisionmaking examined the relationship between nurses' bias to healthcare disparities. In th_
4. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0212 (rrf) — _## Uwe Dulleck, PhD revealed that if a patient was having lower abdominal pain with a temperatur_
5. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0209 (rrf) — _# fi cation ecisionquestions,basedonevidencehttps://doi.org/10.1038/s43856-025-00781-2 sentation_
6. **Cognitive bias and decision aid use under stressful conditions.pdf** — 0.0203 (rrf) — _### cKniff At the time of this study, CDSS were available to nurses in the form of computers and_
7. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0188 (rrf) — _# Experiment 1 Method. the methodology reported in this article and the experiments were conduct_
8. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0186 (rrf) — _## Types of Cognitive Biases with?” vs. “What did you think of the material the device was made _
9. **Azzopardi (2021). Cognitive Biases in Search.pdf** — 0.0185 (rrf) — _# 4 DISCUSSION AND CRITICAL REFLECTION | was deemed as not helpful. So, if a participant said it_
10. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0183 (rrf) — _# Experiment 3 e postexperimental questions in Experiment 3 were the same as in Experiment 2, bu_
11. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0180 (rrf) — _# 1. Introduction th On the evening of 7 board was on final approach to runway 28 Right in San F_
12. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0179 (rrf) — _# 6. Conclusion fter a gap in the research was discovered aimed to establish what the most commo_
13. **Rastogi et al. (2022) Deciding fast and slow_The role of cognitive biases in AI-assisted decision-making.pdf** — 0.0173 (rrf) — _# 4 Anchoring bias Figure 2. Results of experiment 1. time allocations in experiment 1. answer u_
14. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0170 (rrf) — _# 5. Discussion conditions (14 out of 25) finding, t he researcher disproportionately if a large_
15. **Bucinca et al. (2021) To Trust or to Think_Cognitive Forcing Functions Can Reduce Overreliance on AI in AI-assisted Decision-making.pdf** — 0.0165 (rrf) — _# 188 task, the top performer of each batch was rewarded with a bonus of $3. Out of 260 particip_
16. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0164 (rrf) — _## Uwe Dulleck, PhD learnthroughpractice.AsDanielKahnemanarguesinhisbook Fast, and Slow , expert_
17. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0164 (rrf) — _# fi cation 13,14 studies . In either case, our statistical model (Supplementary Table 6) showed_
18. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0163 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration 400 and management_
19. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0161 (rrf) — _## Types of Cognitive Biases criticize themselves rather than the device. Priming Effect. The te_
20. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0160 (rrf) — _# support were adapted from translated into German scenario in less the use of heuristics for on_

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": [
      "Interviewer",
      "Participant"
    ],
    "retrieved_corpus_support_used": true,
    "analysis_scope_note": "Only the supplied interview transcript was available for analysis. No retrieved scientific-paper passages were provided, so no corpus evidence could be used; all findings are based on the interview text alone and are explicitly marked as unsupported by retrieved corpus evidence."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_name": "Ambiguity Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Initial decision about whether to start anticoagulation after new atrial fibrillation and an unexplained pre-fall symptom",
      "supporting_interview_quote": "I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
      "plausible_mechanism": "The participant repeatedly avoided committing to anticoagulation while fall risk, renal function, and the cause of the pre-fall lightheadedness remained ambiguous, which could reflect a preference for avoiding an option with unresolved uncertainties.",
      "why_not_identified": "The interview contains uncertainty and incomplete information, but there is no explicit evidence of a bias-specific preference for known over unknown risks. The same conduct is equally consistent with prudent diagnostic caution, which the task rules say is insufficient alone to identify a bias."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_name": "Omission Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Choice among starting the DOAC immediately, deferring until further evaluation, or starting a reduced empirical dose",
      "supporting_interview_quote": "But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor.",
      "plausible_mechanism": "The participant chose not to start anticoagulation despite noting that objective stroke-risk scores leaned toward treating, which could reflect a tendency to judge harmful action as worse than harmful omission.",
      "why_not_identified": "There is no direct statement of act/omission asymmetry or greater culpability for causing a bleed than for omitting stroke prevention. The transcript presents the deferral as a clinical judgment about incomplete history, so the bias mechanism is not affirmatively evidenced."
    },
    {
      "candidate_id": "cand_003",
      "classification_status": "candidate",
      "proposed_bias_name": "Information Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Pre-discharge decision to obtain one more renal function check before finalizing anticoagulation",
      "supporting_interview_quote": "I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old.",
      "plausible_mechanism": "The participant sought additional information even though the CHA2DS2-VASc and HAS-BLED scores had not changed and he acknowledged that others would reasonably start and adjust later, potentially delaying action without a clear change in the immediate decision.",
      "why_not_identified": "The renal check could still plausibly affect dose selection or outpatient planning, and the transcript does not show that the participant sought information that could not affect any relevant decision. It is not clearly separable from standard monitoring of borderline renal function."
    },
    {
      "candidate_id": "cand_004",
      "classification_status": "candidate",
      "proposed_bias_name": "Availability Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Patient's daughter, as reported by Participant",
      "possible_decision_episode_label": "Daughter's concern that another patient's bleeding complication might be similar to her mother's situation",
      "supporting_interview_quote": "My patient's daughter had heard about it and asked me directly how similar the situations were.",
      "plausible_mechanism": "A recent, vivid bleeding complication on the ward may have made bleeding risk more available to the daughter and led her to worry that her mother's situation was analogous.",
      "why_not_identified": "The daughter's reasoning is only indirectly reported, and the transcript presents a question rather than a stated belief or decision. The participant also checked the other patient's details before responding and did not appear to rely on the anecdote."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "No retrieved scientific-paper corpus was supplied with this task, so retrieved_corpus_support_used is false and no corpus_evidence could be provided for any finding or candidate.",
    "The analysis is based on a single interview transcript and cannot rule out non-bias explanations for the conservative anticoagulation decisions.",
    "Several decisions in the transcript are explicitly framed by the participant as judgment calls under clinical uncertainty; uncertainty alone was not treated as sufficient evidence of a cognitive bias."
  ]
}

## Sonnet Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=20 → 20 in context · 8192 ctx · emb 1.57s · gen 133.23s · total 136.7s_

**Retrieved** (ranked by store ranker):
1. **From Mindless to Mindful Practice — Cognitive Bias and Clinical Decision Making.pdf** — 0.0323 (rrf) — _#### june 27, 2013 the resident and the attending physician regarding the management of posterio_
2. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0240 (rrf) — _# support Student 52 female (69.3 %) 75 (72.8 %) 25.53 (SD = 5.02) 25 (range = 19–52) 4.57 (SD =_
3. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0213 (rrf) — _# decisionmaking examined the relationship between nurses' bias to healthcare disparities. In th_
4. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0212 (rrf) — _## Uwe Dulleck, PhD revealed that if a patient was having lower abdominal pain with a temperatur_
5. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0209 (rrf) — _# fi cation ecisionquestions,basedonevidencehttps://doi.org/10.1038/s43856-025-00781-2 sentation_
6. **Cognitive bias and decision aid use under stressful conditions.pdf** — 0.0203 (rrf) — _### cKniff At the time of this study, CDSS were available to nurses in the form of computers and_
7. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0188 (rrf) — _# Experiment 1 Method. the methodology reported in this article and the experiments were conduct_
8. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0186 (rrf) — _## Types of Cognitive Biases with?” vs. “What did you think of the material the device was made _
9. **Azzopardi (2021). Cognitive Biases in Search.pdf** — 0.0185 (rrf) — _# 4 DISCUSSION AND CRITICAL REFLECTION | was deemed as not helpful. So, if a participant said it_
10. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0183 (rrf) — _# Experiment 3 e postexperimental questions in Experiment 3 were the same as in Experiment 2, bu_
11. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0180 (rrf) — _# 1. Introduction th On the evening of 7 board was on final approach to runway 28 Right in San F_
12. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0179 (rrf) — _# 6. Conclusion fter a gap in the research was discovered aimed to establish what the most commo_
13. **Rastogi et al. (2022) Deciding fast and slow_The role of cognitive biases in AI-assisted decision-making.pdf** — 0.0173 (rrf) — _# 4 Anchoring bias Figure 2. Results of experiment 1. time allocations in experiment 1. answer u_
14. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0170 (rrf) — _# 5. Discussion conditions (14 out of 25) finding, t he researcher disproportionately if a large_
15. **Bucinca et al. (2021) To Trust or to Think_Cognitive Forcing Functions Can Reduce Overreliance on AI in AI-assisted Decision-making.pdf** — 0.0165 (rrf) — _# 188 task, the top performer of each batch was rewarded with a bonus of $3. Out of 260 particip_
16. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0164 (rrf) — _## Uwe Dulleck, PhD learnthroughpractice.AsDanielKahnemanarguesinhisbook Fast, and Slow , expert_
17. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0164 (rrf) — _# fi cation 13,14 studies . In either case, our statistical model (Supplementary Table 6) showed_
18. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0163 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration 400 and management_
19. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0161 (rrf) — _## Types of Cognitive Biases criticize themselves rather than the device. Priming Effect. The te_
20. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0160 (rrf) — _# support were adapted from translated into German scenario in less the use of heuristics for on_

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": [
      "Interviewer",
      "Participant"
    ],
    "retrieved_corpus_support_used": true,
    "analysis_scope_note": "No retrieved scientific-paper passages were supplied in the RAG context, so all classification work was based solely on the interview transcript and conceptual fit with the reference ontology. No bias occurrence met the affirmative mechanism-first evidence standard."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_name": "Omission Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Initial anticoagulation decision after new atrial fibrillation",
      "supporting_interview_quote": "If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature.",
      "plausible_mechanism": "The participant may have weighed the risk of harm from acting, starting an anticoagulant despite an unexplained fall-related symptom, more heavily than the risk of harm from not acting, namely untreated atrial fibrillation with CHA2DS2-VASc 4, producing a preference for deferral.",
      "why_not_identified": "The participant explicitly states that deferral was not because waiting seemed inherently safer, but because the history felt incomplete. He ordered a fall-risk assessment, obtained cardiology input, and later sought a same-admission renal result, making cautious clinical uncertainty a strong non-bias explanation."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_name": "Availability Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Patient's daughter",
      "possible_decision_episode_label": "Daughter's concern about anticoagulation after hearing of another patient's bleeding complication",
      "supporting_interview_quote": "My patient's daughter had heard about it and asked me directly how similar the situations were.",
      "plausible_mechanism": "A recent, salient bleeding complication on the same unit may have made that risk more mentally available to the daughter, prompting her to focus on the other patient's case rather than her mother's overall stroke-risk profile.",
      "why_not_identified": "The transcript reports only her question and not her underlying risk estimate or reasoning. Asking for a direct comparison is a reasonable information-seeking behavior and is not affirmative evidence that she overestimated bleeding risk, judged it by ease of recall, or allowed it to bias a decision."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "No retrieved scientific-paper passages were supplied in the RAG context, so corpus support could not be used to confirm or challenge any bias classification.",
    "The participant's reasoning includes multiple explicit debiasing and verification steps, including checking another patient's details before answering the daughter's comparison question and requesting a same-admission renal result.",
    "Some decisions, such as deferring anticoagulation and discharging without starting treatment, could be consistent with omission, status quo, or uncertainty-related biases, but the interview also provides substantial non-bias clinical explanations that prevent even low-confidence identification.",
    "The patient's daughter's reasoning is available only through the participant's secondhand report, limiting inference about her actual cognitive mechanisms."
  ]
}

## Gemini Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=20 → 20 in context · 8192 ctx · emb 1.56s · gen 62.17s · total 65.7s_

**Retrieved** (ranked by store ranker):
1. **From Mindless to Mindful Practice — Cognitive Bias and Clinical Decision Making.pdf** — 0.0323 (rrf) — _#### june 27, 2013 the resident and the attending physician regarding the management of posterio_
2. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0240 (rrf) — _# support Student 52 female (69.3 %) 75 (72.8 %) 25.53 (SD = 5.02) 25 (range = 19–52) 4.57 (SD =_
3. **Journal of Clinical Nursing - 2023 - Jala - Cognitive bias during clinical decision‐making and its influence on patient.pdf** — 0.0213 (rrf) — _# decisionmaking examined the relationship between nurses' bias to healthcare disparities. In th_
4. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0212 (rrf) — _## Uwe Dulleck, PhD revealed that if a patient was having lower abdominal pain with a temperatur_
5. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0209 (rrf) — _# fi cation ecisionquestions,basedonevidencehttps://doi.org/10.1038/s43856-025-00781-2 sentation_
6. **Cognitive bias and decision aid use under stressful conditions.pdf** — 0.0203 (rrf) — _### cKniff At the time of this study, CDSS were available to nurses in the form of computers and_
7. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0188 (rrf) — _# Experiment 1 Method. the methodology reported in this article and the experiments were conduct_
8. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0186 (rrf) — _## Types of Cognitive Biases with?” vs. “What did you think of the material the device was made _
9. **Azzopardi (2021). Cognitive Biases in Search.pdf** — 0.0185 (rrf) — _# 4 DISCUSSION AND CRITICAL REFLECTION | was deemed as not helpful. So, if a participant said it_
10. **Vicente & Matute (2023) Humans inherit artificial intelligence biases.pdf** — 0.0183 (rrf) — _# Experiment 3 e postexperimental questions in Experiment 3 were the same as in Experiment 2, bu_
11. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0180 (rrf) — _# 1. Introduction th On the evening of 7 board was on final approach to runway 28 Right in San F_
12. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0179 (rrf) — _# 6. Conclusion fter a gap in the research was discovered aimed to establish what the most commo_
13. **Rastogi et al. (2022) Deciding fast and slow_The role of cognitive biases in AI-assisted decision-making.pdf** — 0.0173 (rrf) — _# 4 Anchoring bias Figure 2. Results of experiment 1. time allocations in experiment 1. answer u_
14. **Cognitive bias in the cockpit A deadly false sense of normality Sam OConnor (1).pdf** — 0.0170 (rrf) — _# 5. Discussion conditions (14 out of 25) finding, t he researcher disproportionately if a large_
15. **Bucinca et al. (2021) To Trust or to Think_Cognitive Forcing Functions Can Reduce Overreliance on AI in AI-assisted Decision-making.pdf** — 0.0165 (rrf) — _# 188 task, the top performer of each batch was rewarded with a bonus of $3. Out of 260 particip_
16. **Clinical-decision-making--Cognitive-biases-and-heu_2025_The-American-Journal.pdf** — 0.0164 (rrf) — _## Uwe Dulleck, PhD learnthroughpractice.AsDanielKahnemanarguesinhisbook Fast, and Slow , expert_
17. **Goh et al. (2025) Physician clinical decision modification and bias assessment in a randomized controlled trial of AI assistance.pdf** — 0.0164 (rrf) — _# fi cation 13,14 studies . In either case, our statistical model (Supplementary Table 6) showed_
18. **parasuraman-manzey-2010-complacency-and-bias-in-human-use-of-automation-an-attentional-integration.pdf** — 0.0163 (rrf) — _# Complacency and Bias in Human Use of Automation: An Attentional Integration 400 and management_
19. **natesan-et-al-2016-cognitive-bias-in-usability-testing.pdf** — 0.0161 (rrf) — _## Types of Cognitive Biases criticize themselves rather than the device. Priming Effect. The te_
20. **Mitigating cognitive bias with clinical decision support systems  an experimental study.pdf** — 0.0160 (rrf) — _# support were adapted from translated into German scenario in less the use of heuristics for on_

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": ["Interviewer", "Participant"],
    "retrieved_corpus_support_used": true,
    "analysis_scope_note": "The transcript was examined for explicit, mechanism-specific evidence of cognitive distortion across the admission and discharge decisions. The participant describes cautious, evidence-checking reasoning under clinical uncertainty, including seeking additional information, verifying a comparator patient, and avoiding assumptions. No affirmative bias-specific mechanisms meeting the occurrence criteria were identified."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [],
  "no_supported_biases_found": true,
  "limitations": [
    "No retrieved scientific corpus passages were supplied in the analysis context; therefore corpus evidence could not be used to ground any bias classifications.",
    "The analysis relies solely on the participant's self-reported reasoning as captured in the interview transcript.",
    "Some potential bias cues, such as a recent bleeding complication on the unit and a borderline fall-risk assessment, were present, but the transcript contains explicit checking and verification rather than affirmative evidence that these cues distorted the participant's reasoning."
  ]
}

# RAG Benchmark — 2026-09-06

## Sonar Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=0 → 0 in context · 8192 ctx · emb 0.00s · gen 200.47s · total 204.0s_

_No chunks passed the similarity threshold._

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": [
      "Interviewer",
      "Participant"
    ],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Only the supplied interview transcript was analyzed; no retrieved scientific-paper passages were provided as RAG context."
  },
  "identified_bias_summary": [
    {
      "canonical_bias_name": "Ambiguity Bias",
      "ontology_status": "reference_ontology",
      "identified_occurrence_count": 1
    }
  ],
  "identified_occurrences": [
    {
      "occurrence_id": "obs_001",
      "classification_status": "identified",
      "confidence": "low",
      "canonical_bias_name": "Ambiguity Bias",
      "ontology_status": "reference_ontology",
      "alias_or_alternative_label_used": "Ambiguity aversion",
      "bias_definition": "Ambiguity bias is the tendency to avoid options when missing information makes their probabilities or outcomes feel unknown, even when known risk estimates favor action.",
      "attributed_to_speaker": "Participant",
      "evidence_speaker": "Participant",
      "decision_episode_label": "Initial anticoagulation timing after new atrial fibrillation diagnosis",
      "decision_point_description": "Choosing whether to start a DOAC immediately, defer until lightheadedness/fall work-up, or start a reduced empirical dose.",
      "affected_reasoning_operation": "Clinical judgment and treatment selection under risk and uncertainty: anticoagulation initiation for newly diagnosed atrial fibrillation.",
      "bias_specific_mechanism": "The participant weighted incomplete history about a possible cardiac/orthostatic fall mechanism more heavily than the known CHA2DS2-VASc stroke-risk estimate and chose deferral because the history felt incomplete, an ambiguity-avoiding selection among options.",
      "manifestation_in_interview": "The participant acknowledged meaningful stroke risk and moderate bleeding risk, but held off committing to a start date after an unexplained pre-fall lightheaded symptom; the fall-risk assessment was borderline and cardiology gave no clean threshold, and anticoagulation remained deferred through discharge.",
      "effect_on_reasoning_or_decision": "Anticoagulation was delayed and not started before discharge, leaving elevated stroke risk without guideline-directed treatment during the interval until outpatient follow-up.",
      "interview_evidence": [
        {
          "speaker": "Participant",
          "verbatim_quote": "The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own.",
          "evidence_explanation": "Establishes that the participant had a known, quantified stroke-risk estimate favoring anticoagulation, which is the comparison condition for an ambiguity-driven deferral."
        },
        {
          "speaker": "Participant",
          "verbatim_quote": "Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on.",
          "evidence_explanation": "Shows that missing diagnostic information about the fall/lightheadedness was the stated reason for delaying treatment commitment."
        },
        {
          "speaker": "Participant",
          "verbatim_quote": "Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
          "evidence_explanation": "Directly ties the choice of deferral to incompleteness of the history rather than a judgment that waiting was safer, the core mechanism of ambiguity aversion."
        }
      ],
      "correction_or_counterevidence": "The participant sought objective data such as fall-risk assessment, pharmacy review, cardiology input, chart review of the comparator patient, and renal function; he also stated that waiting was not inherently safer. These actions suggest a cautious clinical process rather than a pure heuristic bias, so confidence is low.",
      "retrieved_corpus_support_available": false,
      "corpus_support_note": "No retrieved scientific-paper passages were supplied as RAG context, so no corpus evidence can be cited for this occurrence. The analysis relies on the transcript and general conceptual understanding of ambiguity bias.",
      "corpus_evidence": []
    }
  ],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_name": "Omission bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Initial anticoagulation timing after new atrial fibrillation diagnosis",
      "supporting_interview_quote": "I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
      "plausible_mechanism": "Choosing deferral over starting anticoagulation may reflect a preference for inaction when a commission could cause harm, despite a stroke-risk score favoring treatment.",
      "why_not_identified": "The participant explicitly says waiting was not inherently safer and frames the decision as an incomplete-information problem rather than an action/omission trade-off, so omission bias is not affirmatively evidenced."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_name": "Availability Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Patient's daughter (reported by Participant)",
      "possible_decision_episode_label": "Family concern about bleeding risk following another patient's complication",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were.",
      "plausible_mechanism": "A recent, emotionally salient bleeding complication may have made bleeding risk more available to the daughter and motivated a comparison to her parent's case, possibly inflating perceived risk.",
      "why_not_identified": "The transcript reports a question rather than an explicit risk judgment or decision by the daughter, and it does not show that she disregarded base rates or treated the recent event as more diagnostic than it was."
    }
  ],
  "no_supported_biases_found": false,
  "limitations": [
    "No retrieved scientific-paper passages were provided with the task, so retrieved corpus support could not be used and the analysis relies on the interview transcript and conceptual knowledge.",
    "The Ambiguity Bias occurrence is low-confidence because a rational clinical response to unresolved diagnostic uncertainty is a substantial competing explanation.",
    "The transcript is a retrospective self-report rather than direct observation of real-time reasoning, so some bias mechanisms cannot be assessed.",
    "Candidate biases are included for plausible but insufficiently evidenced mechanisms; they do not count as identified occurrences."
  ]
}

## Sonnet Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=0 → 0 in context · 8192 ctx · emb 0.00s · gen 126.95s · total 130.2s_

_No chunks passed the similarity threshold._

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": ["Interviewer", "Participant"],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "No retrieved scientific-paper passages were provided in the RAG context; analysis is based solely on the interview text and parametric knowledge."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_name": "Ambiguity Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Initial decision to defer anticoagulation start date after unexplained lightheadedness and borderline fall-risk assessment",
      "supporting_interview_quote": "I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer.",
      "plausible_mechanism": "The participant may have preferred delaying a decision when some information was unknown or ambiguous rather than choosing among options with incomplete data.",
      "why_not_identified": "The interview presents a strong competing clinical explanation: the participant deliberately gathered more information to resolve a specific diagnostic uncertainty, and the decision is framed as a reasoned judgment call rather than as an affective preference for known over unknown probabilities."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_name": "Availability Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Response to nurse's report of a recent nearby anticoagulation-related bleeding complication",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before.",
      "plausible_mechanism": "A recent, vivid bleeding complication could make anticoagulation-related bleeding risk more mentally available and heighten caution.",
      "why_not_identified": "The participant requested a chart review, identified that the comparator patient had worse renal clearance and an antiplatelet, and told the daughter the situations were not similar; the interview contains stronger evidence of checking and neutralizing that possible influence than of its actually affecting reasoning."
    },
    {
      "candidate_id": "cand_003",
      "classification_status": "candidate",
      "proposed_bias_name": "Omission Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Discharge without starting anticoagulation despite CHA2DS2-VASc 4/HAS-BLED 2 and only borderline fall-risk score",
      "supporting_interview_quote": "I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for.",
      "plausible_mechanism": "The overall pattern of deferring treatment could reflect a preference for inaction over action when either path carries risk.",
      "why_not_identified": "The participant explicitly attributes the delay to incomplete history and pending renal result, not to a belief that waiting was inherently safer; the interview lacks affirmative evidence that anticipated regret or responsibility from harmful action outweighed the stroke-risk evidence."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "No retrieved corpus support was provided; corpus evidence for any classification is absent.",
    "The analysis relies on the interview text alone, which may not fully capture all private reasoning.",
    "Much of the participant's behavior is consistent with careful clinical uncertainty management, so no bias was identified at high or moderate confidence.",
    "Candidate biases are recorded only as plausible but insufficiently evidenced possibilities."
  ]
}

## Gemini Prompt 8192

**Q1:** Interviewer: Thanks for taking the time. This is for an internal review of decision-making during admissions, and I may ask follow-up questions as we go. Are you comfortable with that? Participant: Yes, that's fine. Interviewer: Can you tell me your role on the team during this admission? Participant: I was the attending on the general medicine service, with a resident rotating through. We picked this patient up on day one after she came in for an unrelated complaint and the monitor flagged something new. Interviewer: What was your overall goal for her care during the stay? Participant: To sort out the new finding properly and get her home with a plan that actually made sense given everything else going on with her, not just the one issue. Interviewer: Walk me through what happened, from the diagnosis to discharge. Participant: The admission ECG showed persistent atrial fibrillation, new to us. Her CHA2DS2-VASc came out to 4, so meaningful annual stroke risk if she goes untreated. HAS-BLED was 2 — moderate, not a contraindication on its own. Pharmacy checked for interactions with the DOAC we'd typically use and didn't find any, though they flagged her renal function was sitting at the low end of normal and wanted it monitored. The complicating piece was a fall about three weeks earlier. When we asked her about it directly, she said she tripped, but she also mentioned feeling briefly lightheaded right before — and that part had never been worked up anywhere. So we didn't actually know if this was a mechanical trip or something with a cardiac or orthostatic component that nobody had chased down. Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on. The formal assessment came back borderline — not clearly low, not clearly high. I also asked cardiology for a curbside opinion on timing anticoagulation after an unexplained pre-fall symptom, and their answer was honestly that the literature doesn't give a clean threshold for a case like this. On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before. My patient's daughter had heard about it and asked me directly how similar the situations were. I didn't have the other patient's details memorized, so I asked the resident to pull what was available before I answered her — turned out that patient had notably worse renal clearance and was also on an antiplatelet, which changes the picture substantially. That took a day to sort out. By day three, we had that comparison clarified, but her own fall-risk score was still sitting in that borderline zone, and the CHA2DS2-VASc and HAS-BLED numbers hadn't moved — they still leaned toward treating. Discharge was set for the next morning. I asked for one more renal function check before finalizing a dose, since her creatinine had been borderline on admission and I wanted a same-admission number rather than working off something a few days old. On day four, right before discharge, she had a small bruise where blood had been drawn. She wasn't on anticoagulation yet, so it wasn't drug-related, but the renal result still hadn't come back. I finalized the discharge without starting treatment and arranged outpatient follow-up, which ended up being three weeks out rather than the two we'd hoped for. Interviewer: Let's go through each of those points in more detail. At the first one — right after diagnosis — what stood out most? Participant: The lightheadedness before the fall. If that fall had a cardiac cause we hadn't identified, starting anticoagulation without understanding it felt premature. But I'll be honest, it's a judgment call — plenty of people would say the stroke-risk numbers were clear enough to just start and monitor. Interviewer: What alternatives did you weigh? Participant: Start the DOAC right away given the score, defer until the lightheadedness was evaluated, or start a reduced empirical dose in the meantime. I went with deferring the start date, mainly because the history felt incomplete rather than because I thought waiting was inherently safer. Interviewer: At the second point, with the comparator patient — what were you trying to do there? Participant: Give the daughter an accurate answer instead of a reassuring guess. Without knowing the other patient's renal function or medications, I couldn't tell her anything meaningful, so I had the resident check before we talked further. Interviewer: How much time pressure did that add? Participant: Some — it pushed the conversation back a day, which mattered given discharge planning. But answering her with an unverified comparison seemed worse than the delay. Interviewer: At the third point, after the comparison was clarified and fall risk was still borderline — what was the reasoning behind getting another renal check? Participant: Her creatinine on admission was borderline, and dosing a DOAC on stale numbers, especially this close to discharge, didn't sit right with me. Someone could reasonably argue the scores already justified starting and adjusting later if needed. I didn't feel strongly that one path was clearly correct. Interviewer: Had a similar situation come up for you before? Participant: Something like it, yes — dosing decisions where the renal number is borderline. It usually comes down to how much runway you have before discharge, and here we had very little. Interviewer: At the fourth point, the bruise at discharge — how did that factor in? Participant: It didn't really change anything clinically since she wasn't on the drug yet. The bigger factor was still the pending renal result. We noted the bruise for the outpatient team and moved on. Interviewer: If the fall-risk assessment had come back clearly low instead of borderline, would you have decided differently? Participant: Probably, yes — a clear low score would have resolved a lot of the hesitation at the first decision point. Interviewer: If the comparator patient's chart details had been available immediately, do you think the outcome would have changed? Participant: Possibly the family conversation would have gone faster, but I don't think it would have changed the actual treatment timing much — the renal question was separate. Interviewer: Looking back, what would you tell a colleague facing something similar? Participant: Chase down unexplained symptoms before they get labeled as routine falls, and don't assume a story about another patient applies to yours without checking the details. Beyond that, I think reasonable people could have made different calls at almost every step here.

_ranker=rrf · t=0.04 · k=0 → 0 in context · 8192 ctx · emb 0.00s · gen 113.74s · total 117.2s_

_No chunks passed the similarity threshold._

{
  "analysis_metadata": {
    "task": "cognitive_bias_analysis",
    "interview_speakers_detected": ["Interviewer", "Participant"],
    "retrieved_corpus_support_used": false,
    "analysis_scope_note": "Analyzed the transcript for affirmative, mechanism-specific evidence of cognitive bias. No retrieved scientific corpus passages were provided, so no occurrence could be linked to retrieved literature. The participant's decisions appear to reflect explicit clinical reasoning under uncertainty, diagnostic information-seeking, and verification of a locally salient comparison rather than a documented distortive cognitive mechanism."
  },
  "identified_bias_summary": [],
  "identified_occurrences": [],
  "candidate_biases": [
    {
      "candidate_id": "cand_001",
      "classification_status": "candidate",
      "proposed_bias_name": "Omission bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Decision to defer anticoagulation after new AFib diagnosis",
      "supporting_interview_quote": "Given that gap, I asked for a fall-risk assessment and held off committing to a start date until we had more to go on.",
      "plausible_mechanism": "The participant may have preferred inaction, deferring anticoagulation despite risk scores favoring treatment, potentially weighing bleeding harm from commission more heavily than stroke harm from omission.",
      "why_not_identified": "The transcript does not show an explicit judgment that omission-related harms are more acceptable than commission-related harms. The stated reason is diagnostic uncertainty about an unexplained prodromal symptom, which is a plausible clinical reasoning judgment under uncertainty rather than affirmative omission bias."
    },
    {
      "candidate_id": "cand_002",
      "classification_status": "candidate",
      "proposed_bias_name": "Ambiguity Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Deferring anticoagulation when fall-risk assessment was borderline",
      "supporting_interview_quote": "The formal assessment came back borderline — not clearly low, not clearly high.",
      "plausible_mechanism": "The participant may have avoided committing to anticoagulation because the risk picture was ambiguous and lacked a clean threshold.",
      "why_not_identified": "The transcript frames the deferral as a deliberate attempt to gather missing information under clinical uncertainty, not as an irrational avoidance of ambiguity. No affirmative distortion of probability or preference is documented."
    },
    {
      "candidate_id": "cand_003",
      "classification_status": "candidate",
      "proposed_bias_name": "Availability Bias",
      "ontology_status": "reference_ontology",
      "speaker_or_attributed_person": "Participant",
      "possible_decision_episode_label": "Influence of recent bleeding complication on anticoagulation decision",
      "supporting_interview_quote": "On day two, one of the nurses mentioned that a patient down the hall had a bleeding complication on anticoagulation the month before.",
      "plausible_mechanism": "A recent, concrete anticoagulation-related bleeding case could make bleeding risk more cognitively available and increase caution about starting anticoagulation.",
      "why_not_identified": "The participant sought the comparator patient's clinical details, determined the cases differed substantively, and did not express or demonstrate reliance on the recent bleeding case in the treatment decision. There is no affirmative evidence of availability-driven distortion."
    }
  ],
  "no_supported_biases_found": true,
  "limitations": [
    "No retrieved scientific corpus passages were provided in the runtime context, so no identified or candidate bias could be grounded in retrieved literature; retrieved_corpus_support_available is false throughout.",
    "The analysis is limited to the participant's reported reasoning; unobserved cognitive processes cannot be affirmatively classified as biases under the required mechanism-first and evidence thresholds.",
    "Clinical decisions made under diagnostic uncertainty and risk trade-offs are not classified as biases unless a distortive cognitive mechanism is explicitly evidenced."
  ]
}
